Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Today, we're going to take a look at several stocks that made us gains of 50% or better in 2014 and are set for further success in 2015.
I launched my Strategic Tech Investor service in March 2013 with one goal in mind – to help you greatly improve your net worth.
My initial column was titled "The Road to Wealth Is Paved by Tech."
And that proved true through all of 2014 when nearly two dozen tech stocks I recommended beat the market – demonstrating that if you pick the right stocks and manage them properly, you can beat Wall Street at its own game.
Even better, I'll show you why these five tech stocks still have plenty of upside in 2015 and beyond.
A Good Problem to Have
The tech-centric Nasdaq Composite Index was up 15% in 2014, so ours was no small accomplishment. And remember that the volatility we've seen over the first few weeks of 2015 really got its start early last year.
These were such big gains that, had you followed my portfolio management advice, you would have taken a "free trade" on four of these tech stocks.
The "free trade" is a very powerful tool for maximizing your profits.
It works like this. Once a stock in your portfolio has doubled in value, you automatically sell half and recoup all of your original capital.
At that point, you really are working with free money. You've covered your initial investment and are now literally playing with the "house's money."
Now, I expect even more volatility throughout 2015. But I'm optimistic that our five biggest winners of 2014 will continue to generate more profits ahead for one simple reason.
Each meets the mandate of Rule No. 3 of my five-part system for building tech wealth. That rule says to "Ride the unstoppable trends."
With that in mind, let's take a look at our five biggest winners of 2014.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
tech. would be fav . right now.mike is saying with this 25 yrs of lean times coming, tech seems to get into.
My note to Repligen: p/e = 72, PEG = 2,38, dividend = 0. You are surely a quite bold man! In comparison: Rite Aids, p/e = 28, PEG = 0.98, dividend = 0. In regard to overvalued US stockmarket is it advisable to be cautious. Probably you are right, but what are the forces in the background of Repligen?